How Much Do You Know About Acs?

10 Questions | Total Attempts: 383

SettingsSettingsSettings
Please wait...
How Much Do You Know About Acs?

Test your knowledge about the screening, treatment, management and prevention of ACS events.


Questions and Answers
  • 1. 
    Which of the following is the initial treatment regimen for patients with ACS?
    • A. 

      Aspirin, clopidogrel, unfractionated heparin or low–molecular-weight heparin, IV platelet glycoprotein IIb/IIIa complex blockers and a beta-blocker

    • B. 

      Morphine for pain, oxygen, sublingual or IV nitroglycerin, soluble aspirin between 162 mg and 325 mg and clopidogrel between 300 mg and 600 mg loading dose

    • C. 

      None of the above

  • 2. 
    What did the recent SOLID-TIMI 52 trial find regarding treatment with darapladib?
    • A. 

      Darapladib failed to reduce the risk for coronary events when compared with placebo

    • B. 

      Darapladib reduced the risk for coronary events when compared with placebo

    • C. 

      Darapladib led to a 67% death rate

  • 3. 
    In 2012, which medication did the FDA reject as a treatment for patients with ACS?
    • A. 

      Rivaroxaban

    • B. 

      Clopidogrel

    • C. 

      Prasugrel

  • 4. 
    Other than obesity, which of the following health conditions is associated with an increased risk for ACS?
    • A. 

      Rhinosinusitis

    • B. 

      Allergies

    • C. 

      Insomnia

  • 5. 
    Which of the following is the most common symptom of ACS?
    • A. 

      Chest pain

    • B. 

      Cough

    • C. 

      Lethargy

  • 6. 
    Chest pain that is unpredictable and gets worse even with rest is a symptom of which of the following?
    • A. 

      Diabetes

    • B. 

      Salmonella

    • C. 

      Unstable angina

  • 7. 
    Which of the following is a test used to diagnose ACS?
    • A. 

      ECG

    • B. 

      Mammogram

    • C. 

      Glucose test

  • 8. 
    Although delays are known to occur throughout emergency ACS care, which patient group is most affected according to results from the IMMEDIATE trial?
    • A. 

      Men

    • B. 

      Older women

    • C. 

      Women aged between 25 and 45 years

  • 9. 
    Which trial found that the presence of high-risk plaque detected by coronary CTA in the emergency department was associated with an increased risk for ACS in those with acute chest pain?
    • A. 

      OPTIMA

    • B. 

      TRILOGY ACS

    • C. 

      ROMICAT - II

  • 10. 
    In 2011, which of the following medications did the FDA approve for the reduction of MI and CV death in patients with ACS?
    • A. 

      Ticagrelor

    • B. 

      Iron supplementation

    • C. 

      Ibrutinib

Back to Top Back to top